Trial intelligence / Profile preview

Immunity to measles and varicella during and after childhood cancer treatment

2019-004541-33Phase 4Terminated

Sponsor
Region Västra Götaland
Start
Jul 2021
Modality
Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics, Prophylactic Vaccines → Vaccines & Immunotherapeutics, Live Biotherapeutic Products → Microbiome Therapeutics
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of varicella virus vaccine live and measles virus vaccine live in measles and chickenpox, sponsored by Region Västra Götaland. Primary endpoint: Primary research questions. Started Jul 2021; status: terminated.

02

Drugs

varicella virus vaccine livemeasles virus vaccine live
03

Conditions

measleschickenpox

Beyond the preview

Go deeper on 2019-004541-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-004541-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call